Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Giyani Metals' manganese passes Phase 2 battery-grade testing, advancing Botswana project.

Market News
05 May 2026
Proactive Investors
View Source
Bullish
pluang ai news

Giyani Metals Corp announced that its high-purity manganese oxide has passed interim Phase 2 testing by US battery tech firm C4V, marking progress for its K.Hill manganese project in Botswana. The tests showed strong electrode density, cycling stability, and capacity retention, with Phase 2 expected to complete within 60 days. Following this, Phase 3 multi-layer pouch cell testing will begin, lasting about six months. The company is also developing two battery-grade manganese products and expects to release a feasibility study this quarter, supported by a potential $225 million US financing letter of intent.

More News

TGS wins major 4D streamer contract offshore Angola, starting July 2026 for 8 months.

TGS wins major 4D streamer contract offshore Angola, starting July 2026 for 8 months.

TGS ASA has secured a large 4D streamer contract offshore Angola, set to begin data acquisition in early July 2026 and last about eight months. This contract strengthens TGS's strategic presence in Africa and ensures vessel utilization into early 202...

Market News
Bullish
42 minutes ago
argenx to present at major investor conferences in June, highlighting growth and new treatments.

argenx to present at major investor conferences in June, highlighting growth and new treatments.

argenx, a global immunology company focused on autoimmune diseases, announced its management team will present at two key investor conferences in June: the William Blair 46th Annual Growth Stock Conference and the Goldman Sachs 47th Annual Global Hea...

Market News
Bullish
42 minutes ago
Roche launches Liver Disease Panel, a certified algorithm suite for early chronic liver disease detection and management.

Roche launches Liver Disease Panel, a certified algorithm suite for early chronic liver disease detection and management.

Roche has introduced the Liver Disease Panel, the first comprehensive set of certified algorithms designed to improve the detection and management of chronic liver disease (CLD). This panel includes LiverPRO, an algorithm that uses routine blood mark...

Others
Bullish
42 minutes ago
Capgemini targets 5.5-7.5% annual revenue growth by 2028, driven by AI transformation services.

Capgemini targets 5.5-7.5% annual revenue growth by 2028, driven by AI transformation services.

Capgemini unveiled its 2028 strategic plan focusing on leveraging AI agent technology to drive business transformation for large enterprises. The company aims for a 5.5% to 7.5% annual revenue growth from 2025 to 2028, with about 2 points from merger...

Market News
Bullish
42 minutes ago
Capgemini targets 5.5-7.5% revenue CAGR by 2028, driven by AI transformation and margin expansion.

Capgemini targets 5.5-7.5% revenue CAGR by 2028, driven by AI transformation and margin expansion.

Capgemini announced its strategic direction focused on leveraging agentic AI to drive enterprise-wide transformation and business value. The company aims for a 5.5% to 7.5% compound annual revenue growth rate from 2025 to 2028, with margin expansion ...

Market News
Bullish
42 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App